Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,357 total articles

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Rapport Therapeutics, a clinical-stage biotechnology firm focusing on small molecule precision medicines for neurological and psychiatric disorders, announced participation in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference with scheduled fireside chats in early June 2026. The company highlights…

URBN Reports Record Q1 Sales and Income

URBN Reports Record Q1 Sales and Income

Urban Outfitters, Inc. announced record first-quarter financial results for the period ending April 30, 2026, with net sales increasing 11.4% to $1.48 billion and net income reaching a record $115.7 million. Growth was driven by increases in all major segments: Retail comparable sales rose 5.6%, subscription net sales surged 34.5%, and wholesale sa…

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

Longeveron Inc., a clinical-stage biotechnology company, announced a strategic repositioning focusing on capital efficiency, prioritizing licensing partnerships for its stem cell therapy laromestrocel. The company highlighted its near-term catalyst: the August 2026 data readout from its Phase 2b trial for Hypoplastic Left Heart Syndrome (HLHS), a r…

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

Eledon Pharmaceuticals announced it will present updated and new long-term clinical data from its Phase 2 BESTOW trial and extension study of tegoprubart, an anti-CD40L antibody, aimed at preventing kidney transplant rejection. Presentations will occur at the American Transplant Congress in June 2026, accompanied by a conference call to discuss res…

ScottsMiracle-Gro to Webcast Presentation at the William Blair 46th Annual Growth Stock Conference on June 3, 2026

ScottsMiracle-Gro to Webcast Presentation at the William Blair 46th Annual Growth Stock Conference on June 3, 2026

ScottsMiracle-Gro Company, a leading marketer of branded lawn and garden products in North America, announced that its President and COO, Nate Baxter, and CFO, Mark Scheiwer, will present at the William Blair 46th Annual Growth Stock Conference on June 3, 2026. The presentation will outline current business strategies and be available via live webc…

Star Bulk Carriers Corp. Reports Net Profit of $58.5 Million for the First Quarter of 2026, and Declares Quarterly Dividend of $0.50 Per Share

Star Bulk Carriers Corp. Reports Net Profit of $58.5 Million for the First Quarter of 2026, and Declares Quarterly Dividend of $0.50 Per Share

Star Bulk Carriers Corp., a Nasdaq-listed global dry bulk shipping company, announced robust first quarter 2026 results, including a net income of $58.5 million, significant increases in voyage revenues and EBITDA, improved daily charter rates, and a quarterly dividend of $0.50 per share. The company is executing a fleet renewal plan, delivering ne…

Epsilon Announces 2026 AGM Results

Epsilon Announces 2026 AGM Results

Epsilon Energy Ltd. announced the results of its 2026 Annual General Meeting, confirming that all eight director nominees were elected. Shareholders also approved the re-appointment of BDO USA, LLP as auditors, endorsed executive compensation through a non-binding advisory vote, and approved amendments to the 2020 Equity Incentive Plan.

United Fire Group, Inc. declares quarterly cash dividend of $0.20 per share  and announces results of annual meeting of shareholders

United Fire Group, Inc. declares quarterly cash dividend of $0.20 per share and announces results of annual meeting of shareholders

United Fire Group, Inc. declared a quarterly cash dividend of $0.20 per share, payable on June 19, 2026. The board extended and increased the authorized share repurchase program to 2 million shares through August 31, 2028. Five Class A directors were elected to the board with three-year terms, and shareholders approved several corporate governance …

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company, announced its upcoming presentations at the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference. The company's leadership will provide corporate overviews and engage with investors, sharing details about their lead product cand…

Osisko Development Announces Proposed Offering of US$275.0 Million Aggregate Principal Amount of Convertible Senior Notes

Osisko Development Announces Proposed Offering of US$275.0 Million Aggregate Principal Amount of Convertible Senior Notes

Osisko Development Corp. plans to raise US$275 million through a private placement of convertible senior notes, with proceeds to finance development of its Cariboo Gold Project and general corporate needs. The offering includes provisions for capped call transactions to mitigate dilution risk and features an option for additional notes issuance. Th…

WTW Announces Regular Quarterly Dividend

WTW Announces Regular Quarterly Dividend

WTW declared a regular quarterly cash dividend of $0.96 per share for the quarter ended March 31, 2026, payable on July 15, 2026. The dividend declaration reflects the company's steady financial health and commitment to returning value to shareholders. WTW is a global advisory and broking firm operating across 140 countries providing data-driven so…

Cytokinetics to Hold Annual Meeting of Stockholders

Cytokinetics to Hold Annual Meeting of Stockholders

Cytokinetics, a US-based specialty cardiovascular biopharmaceutical company, announced its Annual Meeting of Stockholders to be held on May 27, 2026. Following the meeting, CEO Robert I. Blum will present an overview of the company's performance. The company is continuing to advance its pipeline of potential medicines targeting cardiac muscle dysfu…

TrustCo Announces Declaration of Quarterly Dividend of $0.38 Per Share; Notes Strong Shareholder Support at 2026 Annual Meeting

TrustCo Announces Declaration of Quarterly Dividend of $0.38 Per Share; Notes Strong Shareholder Support at 2026 Annual Meeting

TrustCo Bank Corp NY announced a quarterly cash dividend of $0.38 per share, reflecting confidence in the company’s solid performance and capital strategy. The dividend is payable on July 1, 2026, to shareholders of record as of June 5, 2026. Leadership highlighted strong shareholder support at the recent annual meeting as validation of the bank’s …

AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement

AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement

AIM ImmunoTech Inc. has entered definitive agreements for a $2.4 million registered direct offering of common stock priced at the market, along with a concurrent private placement of Series I Warrants exercisable over five years. Proceeds will fund the manufacture of clinical drug supply, Phase 3 clinical trials, and working capital. The company fo…

TowneBank Announces Quarterly Cash Dividend

TowneBank Announces Quarterly Cash Dividend

TowneBank declared a second-quarter cash dividend of $0.28 per share, a 3.7% increase from the previous dividend rate, payable on July 10, 2026. Following the April 2026 sale of its Resort Property Management business for $250 million and the payment of a special $0.70 per share dividend, the Board approved a one-time $25 million donation to the To…

Park Aerospace Corp. Announces Date of Fourth Quarter and Fiscal Year Earnings Release and Conference Call

Park Aerospace Corp. Announces Date of Fourth Quarter and Fiscal Year Earnings Release and Conference Call

Park Aerospace Corp. announced that it will release its financial results for the fourth quarter and fiscal year ended March 1, 2026, after the NYSE closes on May 28, 2026. A conference call discussing these results will take place the same day, with live webcast and replay options provided. The company specializes in advanced composite materials a…

HII Showcases Next-Generation Autonomous Unmanned Maritime and LVC Capabilities at Combined Naval Event 2026

HII Showcases Next-Generation Autonomous Unmanned Maritime and LVC Capabilities at Combined Naval Event 2026

HII showcased its next-generation autonomous unmanned maritime systems and live, virtual, constructive (LVC) capabilities at the Combined Naval Event 2026 in the UK. The company emphasized its REMUS UUV and ROMULUS USV families, milestone achievements including torpedo tube launch and recovery of UUVs, expanded European operations, and collaboratio…

Verizon to redeem debt securities on June 20, 2026

Verizon to redeem debt securities on June 20, 2026

Verizon Communications Inc. has announced that it will redeem approximately $1.295 billion of its outstanding 4.329% notes due 2028 on June 20, 2026. The redemption price will be based on the greater of the principal amount or the discounted present value of remaining payments plus accrued interest, as specified in the note terms. The redemption in…